Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats

Detalhes bibliográficos
Autor(a) principal: Santos-Junior, Jair Guilherme [UNIFESP]
Data de Publicação: 2002
Outros Autores: Do Monte, F.h.m., Russi, M., Agustine, P.e., Lanziotti, Vanusa Maria Nascimento Bispo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/001300000b36f
DOI: 10.1590/S0100-879X2002000400010
Texto Completo: http://dx.doi.org/10.1590/S0100-879X2002000400010
http://repositorio.unifesp.br/handle/11600/1411
Resumo: Venlafaxine, an atypical antidepressant drug, has been used to treat several neurological disorders, presenting excellent efficacy and tolerability. Clinical seizures after venlafaxine treatment have occasionally been reported when the drug was used at very high doses or in combination with other medications. The aim of the present study was to investigate the convulsant effects of venlafaxine in rats under controlled laboratory conditions. Adult male Wistar rats (8 per group) receiving venlafaxine or saline at the doses of 25-150 mg/kg were subjected 30 min later to injections of pentylenetetrazole at the dose of 60 mg/kg. The animals receiving 75, 100 and 150 mg/kg venlafaxine presented increased severity of convulsion when compared to controls (P = 0.02, P = 0.04, and P = 0.0004, respectively). Indeed, an increased percentage of death was observed in these groups (50, 38, and 88%, respectively) when compared to the percentage of death in the controls (0%). The group receiving 150 mg/kg showed an reduction in death latency (999 ± 146 s) compared to controls (1800 ± 0 s; cut-off time). Indeed, in this group, all animals developed seizures prior to pentylenetetrazole administration. Surprisingly, the groups receiving venlafaxine at the doses of 25 and 50 mg/kg showed a tendency towards an increase in the latency to the first convulsion. These findings suggest that venlafaxine at doses of 25 and 50 mg/kg has some tendency to an anticonvulsant effect in the rat, whereas doses of 75, 100 and 150 mg/kg presented clear proconvulsant effects in rats submitted to the pentylenetetrazole injection. These findings are the first report in the literature concerning the role of venlafaxine in seizure genesis in the rat under controlled conditions.
id UFSP_6ed3baf91c4130a75f06212d7471aa77
oai_identifier_str oai:repositorio.unifesp.br/:11600/1411
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive ratsAntidepressantVenlafaxineConvulsionEpilepsyPentylenetetrazoleVenlafaxine, an atypical antidepressant drug, has been used to treat several neurological disorders, presenting excellent efficacy and tolerability. Clinical seizures after venlafaxine treatment have occasionally been reported when the drug was used at very high doses or in combination with other medications. The aim of the present study was to investigate the convulsant effects of venlafaxine in rats under controlled laboratory conditions. Adult male Wistar rats (8 per group) receiving venlafaxine or saline at the doses of 25-150 mg/kg were subjected 30 min later to injections of pentylenetetrazole at the dose of 60 mg/kg. The animals receiving 75, 100 and 150 mg/kg venlafaxine presented increased severity of convulsion when compared to controls (P = 0.02, P = 0.04, and P = 0.0004, respectively). Indeed, an increased percentage of death was observed in these groups (50, 38, and 88%, respectively) when compared to the percentage of death in the controls (0%). The group receiving 150 mg/kg showed an reduction in death latency (999 ± 146 s) compared to controls (1800 ± 0 s; cut-off time). Indeed, in this group, all animals developed seizures prior to pentylenetetrazole administration. Surprisingly, the groups receiving venlafaxine at the doses of 25 and 50 mg/kg showed a tendency towards an increase in the latency to the first convulsion. These findings suggest that venlafaxine at doses of 25 and 50 mg/kg has some tendency to an anticonvulsant effect in the rat, whereas doses of 75, 100 and 150 mg/kg presented clear proconvulsant effects in rats submitted to the pentylenetetrazole injection. These findings are the first report in the literature concerning the role of venlafaxine in seizure genesis in the rat under controlled conditions.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de PsicobiologiaUniversidade do Estado de Santa Catarina Centro de Ciências Agroveterinárias Departamento de MorfofisiologiaUNIFESP, EPM, Depto. de PsicobiologiaSciELOAssociação Brasileira de Divulgação CientíficaUniversidade Federal de São Paulo (UNIFESP)Universidade do Estado de Santa Catarina Centro de Ciências Agroveterinárias Departamento de MorfofisiologiaSantos-Junior, Jair Guilherme [UNIFESP]Do Monte, F.h.m.Russi, M.Agustine, P.e.Lanziotti, Vanusa Maria Nascimento Bispo2015-06-14T13:29:40Z2015-06-14T13:29:40Z2002-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion469-472application/pdfhttp://dx.doi.org/10.1590/S0100-879X2002000400010Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 4, p. 469-472, 2002.10.1590/S0100-879X2002000400010S0100-879X2002000400010.pdf0100-879XS0100-879X2002000400010http://repositorio.unifesp.br/handle/11600/1411WOS:000175259700010ark:/48912/001300000b36fengBrazilian Journal of Medical and Biological Researchinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-29T17:37:50Zoai:repositorio.unifesp.br/:11600/1411Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:08:28.936427Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
title Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
spellingShingle Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
Santos-Junior, Jair Guilherme [UNIFESP]
Antidepressant
Venlafaxine
Convulsion
Epilepsy
Pentylenetetrazole
Santos-Junior, Jair Guilherme [UNIFESP]
Antidepressant
Venlafaxine
Convulsion
Epilepsy
Pentylenetetrazole
title_short Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
title_full Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
title_fullStr Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
title_full_unstemmed Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
title_sort Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
author Santos-Junior, Jair Guilherme [UNIFESP]
author_facet Santos-Junior, Jair Guilherme [UNIFESP]
Santos-Junior, Jair Guilherme [UNIFESP]
Do Monte, F.h.m.
Russi, M.
Agustine, P.e.
Lanziotti, Vanusa Maria Nascimento Bispo
Do Monte, F.h.m.
Russi, M.
Agustine, P.e.
Lanziotti, Vanusa Maria Nascimento Bispo
author_role author
author2 Do Monte, F.h.m.
Russi, M.
Agustine, P.e.
Lanziotti, Vanusa Maria Nascimento Bispo
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade do Estado de Santa Catarina Centro de Ciências Agroveterinárias Departamento de Morfofisiologia
dc.contributor.author.fl_str_mv Santos-Junior, Jair Guilherme [UNIFESP]
Do Monte, F.h.m.
Russi, M.
Agustine, P.e.
Lanziotti, Vanusa Maria Nascimento Bispo
dc.subject.por.fl_str_mv Antidepressant
Venlafaxine
Convulsion
Epilepsy
Pentylenetetrazole
topic Antidepressant
Venlafaxine
Convulsion
Epilepsy
Pentylenetetrazole
description Venlafaxine, an atypical antidepressant drug, has been used to treat several neurological disorders, presenting excellent efficacy and tolerability. Clinical seizures after venlafaxine treatment have occasionally been reported when the drug was used at very high doses or in combination with other medications. The aim of the present study was to investigate the convulsant effects of venlafaxine in rats under controlled laboratory conditions. Adult male Wistar rats (8 per group) receiving venlafaxine or saline at the doses of 25-150 mg/kg were subjected 30 min later to injections of pentylenetetrazole at the dose of 60 mg/kg. The animals receiving 75, 100 and 150 mg/kg venlafaxine presented increased severity of convulsion when compared to controls (P = 0.02, P = 0.04, and P = 0.0004, respectively). Indeed, an increased percentage of death was observed in these groups (50, 38, and 88%, respectively) when compared to the percentage of death in the controls (0%). The group receiving 150 mg/kg showed an reduction in death latency (999 ± 146 s) compared to controls (1800 ± 0 s; cut-off time). Indeed, in this group, all animals developed seizures prior to pentylenetetrazole administration. Surprisingly, the groups receiving venlafaxine at the doses of 25 and 50 mg/kg showed a tendency towards an increase in the latency to the first convulsion. These findings suggest that venlafaxine at doses of 25 and 50 mg/kg has some tendency to an anticonvulsant effect in the rat, whereas doses of 75, 100 and 150 mg/kg presented clear proconvulsant effects in rats submitted to the pentylenetetrazole injection. These findings are the first report in the literature concerning the role of venlafaxine in seizure genesis in the rat under controlled conditions.
publishDate 2002
dc.date.none.fl_str_mv 2002-04-01
2015-06-14T13:29:40Z
2015-06-14T13:29:40Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0100-879X2002000400010
Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 4, p. 469-472, 2002.
10.1590/S0100-879X2002000400010
S0100-879X2002000400010.pdf
0100-879X
S0100-879X2002000400010
http://repositorio.unifesp.br/handle/11600/1411
WOS:000175259700010
dc.identifier.dark.fl_str_mv ark:/48912/001300000b36f
url http://dx.doi.org/10.1590/S0100-879X2002000400010
http://repositorio.unifesp.br/handle/11600/1411
identifier_str_mv Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 4, p. 469-472, 2002.
10.1590/S0100-879X2002000400010
S0100-879X2002000400010.pdf
0100-879X
S0100-879X2002000400010
WOS:000175259700010
ark:/48912/001300000b36f
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brazilian Journal of Medical and Biological Research
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 469-472
application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1822219216747495424
dc.identifier.doi.none.fl_str_mv 10.1590/S0100-879X2002000400010